EPL Limited Q1FY27: Revenue Surges 25.3% to ₹13,879 Million, EBITDA Up 15.2%
EPL Limited reported a 25.3% revenue increase to ₹13,879 million for Q1FY27. EBITDA grew 15.2% to ₹2,612 million with a 19.6% margin. PAT declined 1.4% to ₹1,518 million. The company is investing in new technologies and saw strong growth across all regions, particularly in 'Personal Care & Beyond' which grew 25.1%.
The significant revenue and EBITDA growth, coupled with strategic investments and expansion in key segments, are material positive developments for the company's financial performance and market position.
The company reported strong double-digit revenue and EBITDA growth, indicating positive business performance. The strategic investments and focus on high-growth segments like 'Personal Care & Beyond' further support a positive outlook.
EPL Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, presenting an investor presentation on August 11, 2026. The company reported a strong performance with a 25.3% year-on-year revenue growth, reaching ₹13,879 million. This growth was driven by broad-based momentum across categories and regions, aided by inflation-led pricing. Underlying revenue growth, excluding commodity pass-through, was 20%, indicating significant acceleration.
Underlying EBITDA saw a 15.2% increase, reaching ₹2,612 million, with an underlying EBITDA margin of 19.6%. The reported EBITDA stood at 18.8% due to commodity inflation pass-through included in revenue. Profit After Tax (PAT) saw a marginal decline of 1.4% to ₹1,518 million, while Profit Before Tax (PBT) increased by 10%. The company expects PAT to deliver double-digit growth for the full year, with the Q1 PAT decline attributed to lapping a low base year ETR.
Return on Capital Employed (ROCE) remained strong at 18.5%, with a slight decline of 37 basis points year-on-year, attributed to proactive capital expenditure investments. The company is strategically investing in new technologies, capabilities, and value-added processes to drive future growth. Supply security and margin protection are key principles guiding the management through input cost inflation, particularly due to the Middle East crisis.
Geographically, significant growth was observed across all regions: AMESA (+17.0%), India (+19.9%), EAP (+34.3%), Americas (+29.4%), and Europe (+20.2%). The 'Personal Care & Beyond' segment, which includes Beauty & Cosmetics and Pharma, now constitutes 54% of total revenue and grew by 25.1% year-on-year, highlighting a strategic shift towards this segment. Oral Care revenue also saw a 23.9% year-on-year growth.
EPL highlighted its commitment to sustainability, with 44% of its portfolio now comprising sustainable tubes. The company achieved an EcoVadis Platinum Rating, placing it among the top 1% of companies globally assessed for sustainability. Several of its sites are certified as Zero Waste to Landfill. EPL also received numerous awards and recognitions, including being certified as a 'Great Place to Work' in seven countries and receiving the FIPSA Award for Responsible Packaging.
What to do with a filing like this
EPL Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by EPL Limited. Read the original for the full detail.